Keeping you up to date on recent developments in oncology, including: Study hints cystectomy not the only answer to muscle-invasive bladder cancer; Drugging resistant androgen receptors; ‘Don’t Eat Me’ signal doubles as ‘Don’t Find Me’; New algorithm may aid in oncology drug development.

Keeping you up to date on recent developments in oncology, including: Study supports use of hypofractionated SRT to resection cavity in brain metastases; PDAC subtypes point to targeting strategies; NICE endorses Tagrisso; Nanofibers show well in study of skin cancer.

Keeping you up to date on recent developments in oncology, including: Study finds fluorescence visualization not associated with reduced recurrence of oral cancer; Immunocytokines jump-start anti-glioblastoma immunity; Study backs protons in treatment of localized prostate cancer.

Keeping you up to date on recent developments in oncology, including: New data cast doubt on post-resection radiotherapy for NSCLC; Carcinogens need not be mutagens; Myelin regulatory factor assists pancreatic cancer cells; Deepmedic provides glioblastoma segmentation with sparsified data.

Keeping you up to date on recent developments in oncology, including: Single-cell RNA sequencing may clarify response to chemotherapy; Epigenetic resistance to PARP inhibitors; Researchers eye organ-on-a-chip drug screening model.

Keeping you up to date on recent developments in oncology, including: New algorithm prioritizes breast cancer patients for surgery, chemotherapy; Oxygen grows tumors but shrinks metastasis chances; ‘Fight or flight’ nervous system helps fight tumors, too; Proton beam therapy available in South Florida.

Keeping you up to date on recent developments in oncology, including: Algorithm improves prediction of hepatocellular carcinoma following hepatitis-driven cirrhosis; MTOR-targeting metabolite discovered; Dartmouth’s Thayer School wins NIH grant.

Keeping you up to date on recent developments in oncology, including: Denoising algorithm may boost signal-to-noise ratios in prostate MRI; Cross-reactive immunity helps antitumor response; iBET you I can kill those metastases; Transatlantic assault on cancer announced.

Keeping you up to date on recent developments in oncology, including: Microspheres paired with LHRH perform well in study of triple-negative breast cancer; New partner in crime for AHR; MMA induces epithelial-to-mesenchymal transition; SCCA incidence trending up in U.S.

Keeping you up to date on recent developments in oncology, including: New and less expensive approach to digital PCR may improve cancer detection; Stromal cell subtypes identified in TNBC; Microbiome metabolites as immunotherapy adjuvants; Pandemic significantly impeded breast cancer follow-up.